← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 188개
CGTBiologicstaleAlaunos TherapeuticsPhase 2

Neoantigen specific TCR-T cell drug product (Neoantigen specific TCR-T cell drug product)

Gynecologic Cancer; Colorectal Cancer · Gynecologic Cancer

#GynecologicCancer#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 3상태 DISCONTINUED
ADCBiologicMultitude Therapeutics Inc.Phase 2

AMT-676 (AMT-676)

Colorectal Cancer · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
CGTBiologicstaleOriCell Therapeutics Co., Ltd.Phase 2

CAR-T infusion (CAR-T infusion)

Refractory Metastatic Colorectal Cancer · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 67%임상시험 2상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab + Irinotecan (Cetuximab + Irinotecan)

Advanced Colorectal Cancer · FRα

#FR#Antibody#Phase2#항체#면역항체+3
효능 ORR 2.081%임상시험 2상태 ACTIVE
AntibodystaleEli LillyPhase 3

Cetuximab, Capecitabine (Cetuximab, Capecitabine)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 2상태 ACTIVE
AntibodystaleRochePhase 3

China-approved Bevacizumab (China-approved Bevacizumab)

Metastatic Colorectal Cancer (CRC) · Advanced Non-squamous Non-small-cell Lun

#AdvancedNon-squamousNon-small-ce#Antibody#Phase3#항체#면역항체+3
임상시험 2상태 ACTIVE
AntibodystaleRocheApproved

Oxaliplatin;Capecitabine;Bevacizumab (Oxaliplatin;Capecitabine;Bevacizumab)

Colorectal Cancer; Liver Metastases · Gastric Cancer

#GastricCancer#Antibody#Approved#항체#면역항체+4
임상시험 2상태 ACTIVE
AntibodystaleMerck Sharp & Dohme LLCPhase 2

Robatumumab (Robatumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 DISCONTINUED
ADCBiologicstaleGruppo Oncologico del Nord-OvestPhase 2

Vorbipiprant (Vorbipiprant)

Colorectal Cancer; Resectable Colorectal Carcinoma · Colorectal Cancer

#ColorectalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
CGTBiologicstaleInge Marie SvanePhase 2

Young TIL (Young TIL)

Metastatic Colorectal Cancer; Metastatic Pancreatic Cancer · Advanced Non-Small Cell Lung Cancer

#AdvancedNon-SmallCellLungCancer#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 33.3%임상시험 2상태 RECRUITING
AntibodystaleGenmabPhase 2

Zalutumumab (Zalutumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 ACTIVE
AntibodystaleEli LillyPhase 2

mCapOX plus Cetuximab (mCapOX plus Cetuximab)

Colo-rectal Cancer; Capecitabine · Colorectal Cancer (CRC)

#ColorectalCancerCRC#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 ACTIVE
AntibodystaleEli LillyPhase 2

mFOLFOX6 plus Cetuximab (mFOLFOX6 plus Cetuximab)

Colo-rectal Cancer; Capecitabine · Colorectal Cancer (CRC)

#ColorectalCancerCRC#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 ACTIVE
CGTBiologicstaleShanghai Cell Therapy Group Co.…Phase 1

αPD1-MSLN-CAR T cells (αPD1-MSLN-CAR T cells)

Colorectal Cancer; Ovarian Cancer · Non-small-cell Lung Cancer

#Non-small-cellLungCancer#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 2상태 ACTIVE
AntibodystaleSpanish Cooperative Group for t…Phase 2

8 cycles of mFOLFOX-6 + cetuximab, followed by cetuximab alone until disease progression or early withdrawal. (8 cycles of mFOLFOX-6 + cetuximab, followed by cetuximab alone until disease progression or early withdrawal.)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAmMax Bio, Inc.Phase 2

pembrolizumab (Keytruda, AMG820 and pembrolizumab)

Pancreatic Cancer; Colorectal Cancer · Pancreatic Cancer

#PancreaticCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 0.0%임상시험 1상태 ACTIVE
ADCBiologicstaleAbGenomics B.V Taiwan BranchPhase 1

AbGn-107 (AbGn-107)

Gastric Cancer; Colorectal Cancer · Gastric Cancer

#GastricCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED
AntibodystaleEli LillyPhase 2

Adebrelimab + Cetuximab+ Chemotherapy (Adebrelimab + Cetuximab+ Chemotherapy)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
CGTBiologicstaleCytoMed Therapeutics Pte LtdPhase 1

Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cell (Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cell)

Colorectal Cancer; Triple Negative Breast Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
AntibodystaleShanghai Celfuture Biotech Co.,…Phase 2

Ametumumab (Ametumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE

3 / 10 페이지

← 이전다음 →